Related Experiment Video
Updated: Jul 16, 2026
11:02
Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
Does difluoromethylornithine prevent recurrence in low-risk superficial bladder cancer?
1Department of Urology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA. herrh@mskcc.org
Nature Clinical Practice. Urology
|February 28, 2007
Abstract
No abstract available in PubMed .